Amanote Research
Register
Sign In
Infliximab Leads to a Rapid but Transient Improvement in Endothelial Function in Patients With Primary Systemic Vasculitis
Annals of the Rheumatic Diseases
- United Kingdom
doi 10.1136/ard.2005.043638
Full Text
Open PDF
Abstract
Available in
full text
Categories
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Date
November 3, 2005
Authors
K Raza
Publisher
BMJ
Related search
Infliximab Improves Endothelial Dysfunction in Systemic Vasculitis: A Model of Vascular Inflammation
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Endothelial Function in Mild Primary Hyperparathyroidism
Clinical Endocrinology
Endocrinology
Metabolism
Diabetes
Tetrahydrobiopterin Supplementation Improves Endothelial Function but Does Not Alter Aortic Stiffness in Patients With Rheumatoid Arthritis
Journal of the American Heart Association
Cardiovascular Medicine
Cardiology
Sudden and Rapid Progression of Lung Affectation but Stability in Kidney Function: A Case Report of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
International Medical Case Reports Journal
Medicine
Value of Anti-Infective Chemoprophylaxis in Primary Systemic Vasculitis: What Is the Evidence?
Arthritis Research and Therapy
Rheumatology
Allergy
Immunology
Features of Systemic Immunity in Patients With a Primary “Dry Eye” Syndrome
Medical Immunology (Russia)
Allergy
Immunology
Hypoxia Impairs Systemic Endothelial Function in Individuals Prone to High-Altitude Pulmonary Edema
American Journal of Respiratory and Critical Care Medicine
Pulmonary
Critical Care
Respiratory Medicine
Intensive Care Medicine
Clinical Associations of Vascular Endothelial Growth Factor in Patients With Systemic Sclerosis
Almanac of Clinical Medicine
Patient Perspectives on Switching From Infliximab to Infliximab‐dyyb in Patients With Rheumatologic Diseases in the United States
ACR Open Rheumatology
